Tresiba® (insulin degludec injection) is a long-acting human insulin analog indicated to improve glycemic control in patients 1 year of age and older with diabetes mellitus.
Tresiba® (insulin degludec injection)
Search for Letters
Find documents for this product by entering your search terms in the box below.
Have a Question?
Request information directly from the Novo Nordisk
Medical Information department.
Have a Question?
All fields required.